Mitral regurgitation anatomical pathway

Mitral regurgitation anatomical pathway" refers to the pathophysiological and anatomical mechanisms underlying mitral regurgitation, a common cardiac valvular disorder. Mitral regurgitation is not a molecular target but a condition characterized by incomplete closure of the mitral valve during systole, allowing blood to flow backward from the left ventricle to the left atrium. It may arise from primary (degenerative/organic) causes involving structural abnormalities of the valve apparatus (e.g., leaflet prolapse, chordae rupture) or secondary (functional) causes due to left ventricular or atrial remodeling without primary valve defects. This pathologic process disrupts normal hemodynamic flow, leading to compensatory changes in cardiac chambers and, if untreated, can result in heart failure and other sequelae[1][2][3]. Key context: - This entry does not represent a molecule, gene, receptor, or drug target but rather describes an anatomical and clinical phenomenon[1][2][3]. - Mitral regurgitation is managed by addressing its underlying causes, often involving surgery or interventional cardiology, not by directly targeting a molecular entity.

Other names

Mitral regurgitation pathwayMitral valve regurgitationMR anatomical mechanismMitral valve insufficiency anatomical mechanism